Sana Biotechnology, Inc.

SANA Healthcare Biotechnology

In the quarter to June 2026, EPS grew 43.6% and free cash flow fell 5.46%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.

2.27 0.21 −8.47%
Market cap
$740.9M
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Older periods Sep '25 Dec '25 Mar '26 Jun '26
Total current assets
161.76 148.68 111.69 170.63
Total non-current assets
273.67 268.21 261.90 260.89
Total Assets
435.43 416.89 373.59 431.52
Total current liabilities
35.51 78.73 86.27 123.75
Total non-current liabilities
204.61 177.28 168.09 153.20
Total liabilities
240.12 256.01 254.35 276.95
Common Equity (Total)
195.31 160.88 119.24 154.57
Shareholders Equity (Total)
195.31 160.88 119.24 154.57

Show all line items

In millions of $ except per-share values · columns are period end dates